Source: PHARAMCEUTICAL TECHNOLOGY

Receptos: Celgene acquires biopharmaceutical firm Receptos for $7.2bn

US-based Celgene has completed the acquisition of biopharmaceutical firm Receptos, for $7.2bn.

Read full article »
Receptos's Competitors | Receptos's News | Receptos's Financials
Stay up-to-date with the latest news on Receptos
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Receptos